Raj Satkunasivam

Urology
6560 Fannin St
Houston, TX 77030

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 154 publications

First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma.

First-Line Enfortumab Vedotin Plus Pembrolizumab vs Gemcitabine Plus Cisplatin for Metastatic Urothelial Carcinoma.

Journal: JAMA network open
Published: July 01, 2026

Letter: Urology Publication Output in Potentially Predatory Journals from 2019 to 2024.

Letter: Urology Publication Output in Potentially Predatory Journals from 2019 to 2024.

Journal: The Journal of urology
Published: June 16, 2026

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

Water Vapor Therapy for the Management of Prostate Cancer: The VAPOR 2 Study Initial Results of Ablative Efficacy and Toxicity.

Journal: The Journal of urology
Published: June 10, 2026

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

Journal: Current oncology (Toronto, Ont.)
Published: February 24, 2026

Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada.

Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada.

Journal: JCO oncology practice
Published: January 13, 2026

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis.

Addition of immune checkpoint inhibitors to intravesical BCG for high-risk BCG-naïve non-muscle invasive bladder cancer: Systematic review and meta-analysis.

Journal: BJUI compass
Published: January 02, 2026

Real-World Treatment Patterns and Outcomes of Intraluminal Ablative Therapies in Noninvasive Urethral Carcinoma: A National Cancer Database Analysis.

Real-World Treatment Patterns and Outcomes of Intraluminal Ablative Therapies in Noninvasive Urethral Carcinoma: A National Cancer Database Analysis.

Journal: Current oncology (Toronto, Ont.)
Published: November 29, 2025

Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database.

Comparative analysis of genitourinary toxicity following bladder outlet obstruction procedures in patients before versus after radiotherapy for localized prostate cancer: a retrospective cohort study using the TriNetX database.

Journal: Prostate cancer and prostatic diseases
Published: October 21, 2025

Complications of Robotic Pelvic Lymph Node Dissection for Prostate Cancer: An Analysis of the National Surgical Quality Improvement Program Targeted Prostatectomy Database.

Complications of Robotic Pelvic Lymph Node Dissection for Prostate Cancer: An Analysis of the National Surgical Quality Improvement Program Targeted Prostatectomy Database.

Journal: Current oncology (Toronto, Ont.)
Published: October 07, 2025

Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database.

Real-world functional and oncologic outcomes of prostate gland ablation vs. standard of care therapies for localized prostate: A retrospective cohort study using the TriNetX database.

Journal: Urologic oncology
Published: September 03, 2025

JUOP April 2025: Report on the Third Annual CUReS Symposium-Collaborative Urology Research Symposium at Houston Methodist.

JUOP April 2025: Report on the Third Annual CUReS Symposium-Collaborative Urology Research Symposium at Houston Methodist.

Journal: JU open plus
Published: August 22, 2025

Physician Age and Patient Outcomes: A Systematic Review.

Physician Age and Patient Outcomes: A Systematic Review.

Journal: Journal of general internal medicine
Published: August 09, 2025
Showing 1-12 of 154

Last Updated: 09/26/2026